1.
Lancet Reg Health Am
; 2: 100028, 2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36779036
RESUMO
Patients in Brazil continue to present with late-stage breast cancer. Notwithstanding these figures, policies and programs to overcome this long-lasting scenario have had limited results. We enlist the main barriers for advancing breast cancer diagnosis in Brazil, based on the available evidence, and we propose feasible strategies that may serve as a platform to address this major public health challenge.